Pregnancy outcome in women treated with doxorubicin for childhood cancer
- PMID: 14526329
- DOI: 10.1067/s0002-9378(03)00837-8
Pregnancy outcome in women treated with doxorubicin for childhood cancer
Abstract
Objective: Pregnancy outcome and the effect of pregnancy on cardiac function were assessed in women cured of childhood cancer.
Study design: Forty women who received doxorubicin as part of a chemotherapy protocol for a neoplastic disorder in childhood were followed up at the same center during pregnancy and after delivery.
Results: Thirty-seven women (72 pregnancies) completed follow-up. Pregnancy outcome was favorable in the 29 women with fractional shortening values of >or=30% before pregnancy, and their myocardial function was sustained. In 8 women with fractional shortening of <30% before pregnancy, pregnancy outcome was less favorable; a 19% decrease in fractional shortening was observed after pregnancy, and this finding was not significant (P=.08).
Conclusion: Pregnancy outcome in women who received doxorubicin for malignancy in childhood is generally favorable. However, those with baseline left ventricular dysfunction should be considered at increased risk for worse pregnancy outcome and further deterioration in myocardial function.
Similar articles
-
The impact of doxorubicin and dexrazoxane injection of prepubertal female rats on pregnancy outcome and cardiac function postpartum.Can J Physiol Pharmacol. 2012 Nov;90(11):1527-34. doi: 10.1139/y2012-126. Epub 2012 Nov 13. Can J Physiol Pharmacol. 2012. PMID: 23181280
-
Long term doxorubicin cardiotoxicity in childhood: non-invasive evaluation of the contractile state and diastolic filling.Br Heart J. 1988 Oct;60(4):309-15. doi: 10.1136/hrt.60.4.309. Br Heart J. 1988. PMID: 3190959 Free PMC article.
-
Indium-111-antimyosin scintigraphy in the early detection of heart damage after anthracycline therapy in children.J Clin Oncol. 1999 Apr;17(4):1208. doi: 10.1200/JCO.1999.17.4.1208. J Clin Oncol. 1999. PMID: 10561180
-
Dexrazoxane. A review of its use as a cardioprotective agent in patients receiving anthracycline-based chemotherapy.Drugs. 1998 Sep;56(3):385-403. doi: 10.2165/00003495-199856030-00009. Drugs. 1998. PMID: 9777314 Review.
-
[Congenital heart disease and acquired valvular lesions in pregnancy].Herz. 2003 May;28(3):227-39. doi: 10.1007/s00059-003-2467-y. Herz. 2003. PMID: 12756480 Review. German.
Cited by
-
Asymptomatic cardiac toxicity in long-term cancer survivors: defining the population and recommendations for surveillance.Semin Oncol. 2013 Apr;40(2):229-38. doi: 10.1053/j.seminoncol.2013.01.005. Semin Oncol. 2013. PMID: 23540748 Free PMC article.
-
Brazilian Position Statement on the Use Of Multimodality Imaging in Cardio-Oncology - 2021.Arq Bras Cardiol. 2021 Oct;117(4):845-909. doi: 10.36660/abc.20200266. Arq Bras Cardiol. 2021. PMID: 34709307 Free PMC article. English, Portuguese. No abstract available.
-
Pregnancy and Cardiomyopathy After Anthracyclines in Childhood.Front Cardiovasc Med. 2018 Mar 26;5:14. doi: 10.3389/fcvm.2018.00014. eCollection 2018. Front Cardiovasc Med. 2018. PMID: 29632865 Free PMC article.
-
Women at heart: Introducing gender cardio-oncology.Front Cardiovasc Med. 2022 Nov 23;9:974123. doi: 10.3389/fcvm.2022.974123. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36505385 Free PMC article. Review.
-
Impact of Cancer Therapy-Related Cardiac Dysfunction on Risk of Heart Failure in Pregnancy.JACC CardioOncol. 2020 Jun 16;2(2):153-162. doi: 10.1016/j.jaccao.2020.04.007. eCollection 2020 Jun. JACC CardioOncol. 2020. PMID: 34396225 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical